An LC-MS/MS Method Development and Validation for the Quantification of Infigratinib in K2EDTA Human Plasma. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 16, n. 1, p. 86–91, 2024. DOI: 10.25004/IJPSDR.2024.160112. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/8463.. Acesso em: 16 oct. 2025.